Roswitha Beck

1.7k total citations
36 papers, 1.1k citations indexed

About

Roswitha Beck is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roswitha Beck has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roswitha Beck's work include Radiopharmaceutical Chemistry and Applications (18 papers), Peptidase Inhibition and Analysis (16 papers) and Neuroendocrine Tumor Research Advances (8 papers). Roswitha Beck is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (18 papers), Peptidase Inhibition and Analysis (16 papers) and Neuroendocrine Tumor Research Advances (8 papers). Roswitha Beck collaborates with scholars based in Germany, United Kingdom and United States. Roswitha Beck's co-authors include Markus Schwaiger, Hans‐Jürgen Wester, Alexander Wurzer, Gerald Reischl, Morand Piert, Maria Picchio, H.‐J. Machulla, Hans-Jürgen Wester, Alexander McEwan and Leonard I. Wiebe and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Roswitha Beck

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roswitha Beck Germany	19	585	310	228	216	183	36	1.1k
Antero Abrunhosa Portugal	21	415 0.7×	283 0.9×	311 1.4×	218 1.0×	467 2.6×	88	1.4k
Naosuke Nonoguchi Japan	24	495 0.8×	597 1.9×	198 0.9×	215 1.0×	374 2.0×	81	1.8k
Chi‐Wei Chang Taiwan	21	392 0.7×	167 0.5×	222 1.0×	284 1.3×	452 2.5×	60	1.5k
Franz‐Josef Gildehaus Germany	20	553 0.9×	407 1.3×	166 0.7×	127 0.6×	277 1.5×	35	1.4k
Marcus Unterrainer Germany	28	1.1k 1.8×	591 1.9×	450 2.0×	159 0.7×	214 1.2×	137	2.1k
Janette Carlsen Germany	18	531 0.9×	100 0.3×	241 1.1×	186 0.9×	324 1.8×	23	1.2k
Nobuhiro Hata Japan	22	517 0.9×	223 0.7×	142 0.6×	541 2.5×	623 3.4×	101	1.9k
Aurelio Hernández‐Laín Spain	19	205 0.4×	165 0.5×	201 0.9×	191 0.9×	456 2.5×	88	1.3k
Hans Wester Germany	17	861 1.5×	253 0.8×	375 1.6×	179 0.8×	307 1.7×	50	1.8k
Radim Jančálek Czechia	19	337 0.6×	260 0.8×	122 0.5×	148 0.7×	280 1.5×	75	1.4k

Countries citing papers authored by Roswitha Beck

Since Specialization

Citations

This map shows the geographic impact of Roswitha Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roswitha Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roswitha Beck more than expected).

Fields of papers citing papers by Roswitha Beck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roswitha Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roswitha Beck. The network helps show where Roswitha Beck may publish in the future.

Co-authorship network of co-authors of Roswitha Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Roswitha Beck. A scholar is included among the top collaborators of Roswitha Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roswitha Beck. Roswitha Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fischer, Sebastian, et al.. (2025). Studies on the impact of modifications at the Gln-Trp site in RM2-based GRPR ligands. EJNMMI Research. 15(1). 114–114.

Fischer, Sebastian, et al.. (2024). Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs. EJNMMI Research. 14(1). 23–23. 1 indexed citations

Beck, Roswitha, Alexander Dierks, Christian H. Pfob, et al.. (2023). Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [⁶⁸Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer. Journal of Nuclear Medicine. 65(1). 33–39. 8 indexed citations

Beck, Roswitha, Pascal V. Grundler, Nicholas P. van der Meulen, et al.. (2023). Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with¹⁶¹Tb and¹⁷⁷Lu: A Comparative Study. Journal of Nuclear Medicine. 65(3). 481–484. 12 indexed citations

Wuehr, Max, et al.. (2023). Repetitive Low-Intensity Vestibular Noise Stimulation Partly Reverses Behavioral and Brain Activity Changes following Bilateral Vestibular Loss in Rats. Biomolecules. 13(11). 1580–1580. 1 indexed citations

Schwarzenböck, Sarah M., Jens Kurth, Martin Heuschkel, et al.. (2023). Preclinical Comparison of the⁶⁴Cu- and⁶⁸Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [⁶⁸Ga]Ga-AMTG PET/CT. Journal of Nuclear Medicine. 64(10). 1654–1659. 17 indexed citations

Gunther, Lisa M., Roswitha Beck, Max Wuehr, et al.. (2023). Dose- and application route-dependent effects of betahistine on behavioral recovery and neuroplasticity after acute unilateral labyrinthectomy in rats. Frontiers in Neurology. 14. 1175481–1175481. 4 indexed citations

Konrad, Matthias, et al.. (2022). Optimization of the Pharmacokinetic Profile of [99mTc]Tc-N4-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence. Pharmaceuticals. 15(9). 1133–1133. 6 indexed citations

Wurzer, Alexander, Sebastian Fischer, Roswitha Beck, et al.. (2022). Synthesis and Preclinical Evaluation of ¹⁷⁷Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer. Journal of Nuclear Medicine. 63(10). 1489–1495. 27 indexed citations

10.

Pomorski, Thomas Günther, et al.. (2022). Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in ¹⁷⁷Lu-RM2 Results in ¹⁷⁷Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability. Journal of Nuclear Medicine. 63(9). 1364–1370. 30 indexed citations

11.

Wurzer, Alexander, et al.. (2020). Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics. EJNMMI Research. 10(1). 149–149. 32 indexed citations

12.

Wurzer, Alexander, Alexander Schmidt, Roswitha Beck, et al.. (2019). Radiohybrid Ligands: A Novel Tracer Concept Exemplified by ¹⁸F- or ⁶⁸Ga-Labeled rhPSMA Inhibitors. Journal of Nuclear Medicine. 61(5). 735–742. 95 indexed citations

13.

Schottelius, Margret, Alexander Wurzer, Roswitha Beck, et al.. (2018). Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer. Journal of Nuclear Medicine. 60(1). 71–78. 76 indexed citations

14.

Russmann, Vera, Matthias Brendel, Erik Mille, et al.. (2017). Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy. NeuroImage Clinical. 15. 35–44. 24 indexed citations

15.

Zwergal, Andreas, Guoming Xiong, Roswitha Beck, et al.. (2014). Sequential [18F]FDG µPET whole-brain imaging of central vestibular compensation: a model of deafferentation-induced brain plasticity. Brain Structure and Function. 221(1). 159–170. 45 indexed citations

16.

Schönitzer, Veronika, Florian Haasters, Erik Mille, et al.. (2014). In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and ¹⁸F-Fallypride. Journal of Nuclear Medicine. 55(8). 1342–1347. 18 indexed citations

17.

Beck, Roswitha, Lisa M. Gunther, Guoming Xiong, et al.. (2014). The mixed blessing of treating symptoms in acute vestibular failure — Evidence from a 4-aminopyridine experiment. Experimental Neurology. 261. 638–645. 30 indexed citations

18.

Seidl, Christof, et al.. (2010). 177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi. European Journal of Nuclear Medicine and Molecular Imaging. 38(2). 312–322. 25 indexed citations

19.

Beck, Roswitha, Christof Seidl, Aliyah Morgenstern, et al.. (2007). ²¹³Bi‐radioimmunotherapy defeats early‐stage disseminated gastric cancer in nude mice. Cancer Science. 98(8). 1215–1222. 26 indexed citations

20.

Seidl, Christof, Roswitha Beck, Dieter Saur, et al.. (2007). Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging. European Journal of Nuclear Medicine and Molecular Imaging. 34(6). 841–849. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact